Literature DB >> 33509105

Mild thrombocytopenia indicating maternal organ damage in pre-eclampsia: a cross-sectional study.

Michinori Mayama1, Mamoru Morikawa2, Takashi Yamada3, Takeshi Umazume2, Kiwamu Noshiro2, Kinuko Nakagawa2, Yoshihiro Saito2, Kentaro Chiba2, Satoshi Kawaguchi2, Hidemichi Watari2.   

Abstract

BACKGROUND: Currently, there is a disagreement between guidelines regarding platelet count cut-off values as a sign of maternal organ damage in pre-eclampsia; the American College of Obstetricians and Gynecologists guidelines state a cut-off value of < 100 × 109/L; however, the International Society for the Study of Hypertension in Pregnancy guidelines specify a cut-off of < 150 × 109/L. We evaluated the effect of mild thrombocytopenia: platelet count < 150 × 109/L and ≥ 100 × 109/L on clinical features of pre-eclampsia to examine whether mild thrombocytopenia reflects maternal organ damage in pre-eclampsia.
METHODS: A total of 264 women were enrolled in this study. Participants were divided into three groups based on platelet count levels at delivery: normal, ≥ 150 × 109/L; mild thrombocytopenia, < 150 × 109/L and ≥ 100 × 109/L; and severe thrombocytopenia, < 100 × 109/L. Risk of severe hypertension, utero-placental dysfunction, maternal organ damage, preterm delivery, and neonatal intensive care unit admission were analyzed based on platelet count levels. Estimated relative risk was calculated with a Poisson regression analysis with a robust error.
RESULTS: Platelet counts indicated normal levels in 189 patients, mild thrombocytopenia in 51 patients, and severe thrombocytopenia in 24 patients. The estimated relative risks of severe thrombocytopenia were 4.46 [95 % confidence interval, 2.59-7.68] for maternal organ damage except for thrombocytopenia, 1.61 [1.06-2.45] for preterm delivery < 34 gestational weeks, and 1.35 [1.06-1.73] for neonatal intensive care unit admission. On the other hand, the estimated relative risks of mild thrombocytopenia were 0.97 [0.41-2.26] for maternal organ damage except for thrombocytopenia, 0.91 [0.62-1.35] for preterm delivery < 34 gestational weeks, and 0.97 [0.76-1.24] for neonatal intensive care unit admission.
CONCLUSIONS: Mild thrombocytopenia was not associated with severe features of pre-eclampsia and would not be suitable as a sign of maternal organ damage.

Entities:  

Keywords:  Cut-off value; Maternal organ damage; Pre-eclampsia; Preterm delivery; Thrombocytopenia

Mesh:

Year:  2021        PMID: 33509105      PMCID: PMC7845117          DOI: 10.1186/s12884-021-03564-4

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  16 in total

1.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

Review 2.  Thrombocytopenia in pregnancy.

Authors:  Douglas B Cines; Lisa D Levine
Journal:  Blood       Date:  2017-06-21       Impact factor: 22.113

3.  Increase in the number of patients diagnosed using the new classification of hypertensive disorders of pregnancy in Japan.

Authors:  Michinori Mayama; Mamoru Morikawa; Takeshi Umazume; Kinuko Nakagawa; Ami Hosokawa; Masahiro Yamaguchi; Kentaro Chiba; Satoshi Kawaguchi; Hidemichi Watari
Journal:  J Obstet Gynaecol Res       Date:  2019-03-28       Impact factor: 1.730

4.  Platelets in pregnancy.

Authors:  Piazze Juan; Gioia Stefano; Spagnuolo Antonella; Cerekja Albana
Journal:  J Prenat Med       Date:  2011-10

5.  Thrombocytopenia at delivery: a prospective survey of 6715 deliveries.

Authors:  R F Burrows; J G Kelton
Journal:  Am J Obstet Gynecol       Date:  1990-03       Impact factor: 8.661

6.  Significance of the platelet distribution width as a severity marker for the development of preeclampsia.

Authors:  Seung Woo Yang; Soo Hyun Cho; Han Sung Kwon; In Sook Sohn; Han Sung Hwang
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2014-01-03       Impact factor: 2.435

Review 7.  How I treat thrombocytopenia in pregnancy.

Authors:  Terry Gernsheimer; Andra H James; Roberto Stasi
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

8.  Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.

Authors:  Daniel L Rolnik; David Wright; Liona C Poon; Neil O'Gorman; Argyro Syngelaki; Catalina de Paco Matallana; Ranjit Akolekar; Simona Cicero; Deepa Janga; Mandeep Singh; Francisca S Molina; Nicola Persico; Jacques C Jani; Walter Plasencia; George Papaioannou; Kinneret Tenenbaum-Gavish; Hamutal Meiri; Sveinbjorn Gizurarson; Kate Maclagan; Kypros H Nicolaides
Journal:  N Engl J Med       Date:  2017-06-28       Impact factor: 91.245

9.  Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

Authors:  Harald Zeisler; Elisa Llurba; Frederic Chantraine; Manu Vatish; Anne Cathrine Staff; Maria Sennström; Matts Olovsson; Shaun P Brennecke; Holger Stepan; Deirdre Allegranza; Peter Dilba; Maria Schoedl; Martin Hund; Stefan Verlohren
Journal:  N Engl J Med       Date:  2016-01-07       Impact factor: 91.245

10.  Clinical and pathogenetic features of early- and late-onset pre-eclampsia.

Authors:  Zulfiya S Khodzhaeva; Yevgeniya A Kogan; Roman G Shmakov; Nataliya I Klimenchenko; Albina S Akatyeva; Olga V Vavina; Alexey M Kholin; Kamilla T Muminova; Gennady T Sukhikh
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-02
View more
  1 in total

1.  Comparison of three neuraxial anesthesia approaches in parturient women with obesity and pregnancy-induced hypertension who underwent cesarean section.

Authors:  Jie Li; An-Er Chen; Ren Ye
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.